Whether you're a healthcare provider seeking access to SurGraft® amniotic allografts, a sub-distributor exploring territory rights in your region, or a clinician evaluating advanced regenerative wound care — we welcome the dialogue directly.
All initial inquiries are reviewed personally by ITG leadership. Confidential conversations protected by NDA where required. We respond to qualified inquiries within two business days.